Journal of Hepatology
Volume 51, Issue 6 , Pages 991-999 , December 2009

A novel model of CCl4-induced cirrhosis with ascites in the mouse

  • Marco Domenicali

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Paolo Caraceni

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 051 6362919; fax: +39 051 6362930.
    • ,
  • Ferdinando Giannone

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Maurizio Baldassarre

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Giovanna Lucchetti

      Affiliations

    • Institute of Hematology and Medical Oncology “L. & A. Seragnoli”, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Carmelo Quarta

      Affiliations

    • U.O. Nuclear Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Corrado Patti

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Lucia Catani

      Affiliations

    • Institute of Hematology and Medical Oncology “L. & A. Seragnoli”, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Cristina Nanni

      Affiliations

    • U.O. Nuclear Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Roberto M. Lemoli

      Affiliations

    • Institute of Hematology and Medical Oncology “L. & A. Seragnoli”, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • ,
  • Mauro Bernardi

      Affiliations

    • Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
    • Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy
    • Stem Cell Research Center, Alma Mater Studiorum University of Bologna, Azienda Ospedaliera-Universitaria Policlinico S. Orsola-Malpighi, Bologna, Italy

Received 19 November 2008 ,Revised 6 July 2009 ,Accepted 24 July 2009.

References 

  1. Korpassy B, Kovacs K. Experimental liver cirrhosis in rats produced by prolonged subcutaneous administration of solutions of tannic acid. Br J Exp Pathol. 1949;30:266–272
  2. Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol. 1977;233:572–585
  3. Jiménez W, Cària J, Arroyo V, Rodes J. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease. J Gastroenterol Hepatol. 1992;7:90–97
  4. Domenicali M, Caraceni P, Principe A, Pertosa AM, Ros J, Chieco P, et al. A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. J Hepatol. 2005;43:92–97
  5. Lieber CS, DeCarli LM, Sorrell MF. Experimental methods of ethanol administration. Hepatology. 1989;10:501–510
  6. Zimmermann H, Fellay M, Zimmermann A. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat. J Hepatol. 1997;26:158–166
  7. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med. 2005;117:237–250
  8. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med. 2006;12:671–676
  9. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology. 2002;123:1323–1330
  10. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 2008;95:646–656
  11. Chang ML, Yeh CT, Chang PY, Chen JC. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol. 2005;11:4167–4172
  12. Ackermann D, Mordasini D, Cheval L, Imbert-Teboul M, Vogt B, Doucet A. Sodium retention and ascites formation in a cholestatic mice model: role of aldosterone and mineralocorticoid receptor?. Hepatology. 2007;46:173–179
  13. Geerts AM, Vanheule E, Praet M, Van Vlierberghe H, De Vos M, Colle I. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol. 2008;89:251–263
  14. Domenicali M, Caraceni P, Giannone F, Pertosa AM, Principe A, Zambruni A, et al. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Gastroenterology. 2009;137:341–349
  15. López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin Invest. 1997;100:664–670
  16. Ros J, Fernández-Varo G, Muñoz-Luque J, Arroyo V, Rodés J, Gunnet JW, et al. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention. Br J Pharmacol. 2005;146:654–661
  17. Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. 2006;44:1441–1451
  18. Da Silva Morais A, Abarca-Quinones J, Horsmans Y, Stärkel P, Leclercq IA. Peroxisome proliferated-activated receptor gamma ligand, pioglitazone, does not prevent hepatic fibrosis in mice. Int J Mol Med. 2007;19:105–112
  19. Guimond A, Teletin M, Garo E, D’Sa A, Selloum M, Champy MF, et al. Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice. Liver Int. 2007;27:854–864
  20. Hagiwara S, Otsuka T, Yamazaki Y, Kosone T, Sohara N, Ichikawa T, et al. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury. Liver Int. 2008;28:126–131
  21. Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol. 2008;19:1158–1167
  22. Cameron EM, Wang SY, Fink MP, Sellke FW. Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis. Shock. 1998;9:184–192
  23. Domenicali M, Ros J, Fernández-Varo G, Cejudo-Martín P, Crespo M, Morales-Ruiz M, et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut. 2005;54:522–527
  24. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA. 1997;94:10663–10668

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00630-8

doi: 10.1016/j.jhep.2009.09.008

Journal of Hepatology
Volume 51, Issue 6 , Pages 991-999 , December 2009

Article Tools

* Image Usage & Resolution